Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase NA 2Phase 1/2 2Phase 3 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 1059Neoplasms 885Prostatic Neoplasms 510Lung Neoplasms 426Colorectal Neoplasms 358Motor Activity 226Uterine Cervical Neoplasms 194Head and Neck Neoplasms 194Carcinoma, Non-Small-Cell Lung 182Brain Neoplasms 174Pancreatic Neoplasms 162Ovarian Neoplasms 143Colonic Neoplasms 140Carcinoma, Hepatocellular 136Anxiety Disorders 125Rectal Neoplasms 119Hematologic Neoplasms 115Multiple Myeloma 109Stomach Neoplasms 105Neoplasm Metastasis 100Precursor Cell Lymphoblastic Leukemia-Lymphoma 97Melanoma 93Depression 93Pain 89Urinary Bladder Neoplasms 88Endometrial Neoplasms 87Glioblastoma 86Disease 85Lymphoma 84Sarcoma 78

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Anatomic Stage IV Breast Cancer AJCC v8 × 1 year × Clear all
NCT03723928 2026-04-02

S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer

SWOG Cancer Research Network

Phase NA Recruiting
739 enrolled
Breast

Anatomic Stage IV Breast Cancer AJCC v8

NCT06572800 2025-10-08

Tka Assay for CDK4/6i

Yale University

Phase NA Completed
34 enrolled
Breast

Anatomic Stage IV Breast Cancer AJCC v8

Data powered by HemOnc (CC BY 4.0) Colophon âš¡